Project Manager, AVERT DOSE - AVERT Early Rehabilitation Research Group
Ms Fiona Ellery
BSc

Fiona has a nursing background and has been working in the clinical trials arena for over 25 years.  She has had all levels of trials experiece, initially as a clinical trials coordinator in a number of large teaching and private hospitals. She later worked within the pharmaceutical industry as a clinical research associate, and later a trials consultant, project managing many local and international multi-centre clinical trials. She left to take on a number of leadership initiatives, academic trial management and mentorship during a 12 year tenure at  Neuroscience Trials Australia (NTA). 

Fiona is currently the Platform Operations for the AVERT team where she is the  Project Manager for the large international multicentre AVERT DOSE study, which is exploring the optimal dose of mobility training for stroke patients in the acute phase.  She also plays a mentoring role working closely with academics, in relation to clinical trial design, managment and the day to day implementation of a number of projects. She brings an in depth understanding of regulatory clinical research requirements worldwide. She has a particular passion for working with clinicians, developing and managing academic trials from the concept stage, through to the final publication of results.  She has a particular interest in mentorship and peer support, and is passionate about sharing expertise with new researchers to help them bring a particular regulatory rigour to their work.

Connect with Fiona on Twitter

  • Location

    Florey Institute of Neuroscience and Mental Health, Austin
    245 Burgundy Street
    Heidelberg
    VIC 3084

Research Papers

Showing 10 of 20. VIEW ALL

  • Exploring Efficacy and Safety of Very Early Mobilization Within 24 Hours of Stroke Onset Versus Usual Stroke Unit Care (A Very Early Rehabilitation Trial, AVERT): Pre-specified Subgroup Analysis
    Stroke
    • Volume: 47
    • Page(s): A76--A76
    • Year: 2016
  • Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)(vol 86, pg 2138, 2016)
    NEUROLOGY
    • Volume: 89
    • Page(s): 107--107
    • Year: 2017
  • Prespecified dose-response analysis for a very early rehabilitation trial (AVERT)
    Neurology
    • Volume: 86
    • Page(s): 2138--2145
    • Year: 2016
  • Shorter, More Frequent Out of Bed Activity Very Early After Stroke (AVERT) is Associated With a Favorable Outcome at 3 Months
    Stroke
    • Volume: 47
    • Page(s): A153--A153
    • Year: 2016
  • A randomized controlled trial of very early rehabilitation in speech after stroke
    • Year: 2016
  • Therapy fidelity and trial progress in the Very Early Rehabilitation in SpEech (VERSE) trial
    Annual Scientific Meeting of the Stroke Society of Australasia
    • Year: 2017
  • Economic Evaluation Plan (EEP) for A Very Early Rehabilitation Trial (AVERT): An international trial to compare the costs and cost-effectiveness of commencing out of bed standing and walking training (very early mobilization) within 24 h of stroke onset with usual stroke unit care
    • Year: 2016
  • Therapy fidelity in the Very Early Rehabilitation in SpEech (VERSE) aphasia after stroke randomised controlled trial (RCT): Lessons learned and progress to date
    Speech Pathology Australia National Conference
    • Year: 2016
  • The progress of a complex rehabilitation randomised controlled trial: Very Early Rehabilitation in SpEech (VERSE) after stroke
    Speech Pathology Australia National Conference
    • Year: 2016
  • Implementing a complex rehabilitation intervention in a stroke trial: a qualitative process evaluation of AVERT
    BMC Medical research methodology
    • Volume: 16
    • Page(s): 52
    • Year: 2016
  • trial Status and Recruitment: Very Early Rehabilitation in Speech (verse) after Stroke Trial: p157
    Cerebrovascular Diseases
    • Volume: 42
    • Page(s): 102
    • Year: 2016
  • Commentary on Arias M & Smith L (2007) Early mobilization of acute stroke patients. Journal of Clinical Nursing 16, 282--288
    Journal of clinical nursing
    • Volume: 17
    • Page(s): 1957--1958
    • Year: 2008
  • Establishing large scale therapy fidelity processes inthe Very Early Rehabilitation in SpEech (VERSE) clinical trial: Lessons learned
    International Journal of Stroke
    • Year: 2015
  • AVERT2 (a very early rehabilitation trial, a very effective reproductive trigger): retrospective observational analysis of the number of babies born to trial staff
    Bmj
    • Volume: 351
    • Page(s): h6432
    • Year: 2015
  • A Bahasa Malaysia version of the Montreal Cognitive Assessment: validation in stroke
    International psychogeriatrics
    • Volume: 26
    • Page(s): 781--786
    • Year: 2014
  • what ‘dose’of mobilisation improves outcome? Dose response analysis of A Very Early Rehabilitation Trial (avert)
    International Journal of Stroke
    • Volume: 10
    • Page(s): 34--35
    • Year: 2015
  • implementing the Avert early rehabilitation protocol in acute stroke units: A qualitative study
    International Journal of Stroke
    • Volume: 10
    • Page(s): 11--12
    • Year: 2015
  • a Very Early Rehabilitation Trial (avert): Outcome at 12 Months: 006
    Cerebrovascular Diseases
    • Volume: 42
    • Page(s): 3
    • Year: 2016
  • Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial
    Lancet
    • Volume: 386
    • Page(s): 46--55
    • Year: 2015
  • Very Early Rehabilitation in SpEech (VERSE) after stroke: trial status and recruitment
    European Stroke Organisation Conference
    • Year: 2016

Showing 10 of 20. VIEW ALL

Support us

Brain health affects all Australians.
You can support our research by making a donation or a bequest.

Newsletter

Latest breakthroughs, news, events & more.